CibusDx met with the Economic Development Board of the Government of Singapore on September 11, 2017 to discuss mutual potential business interests. The meeting was the conclusion of a series of successful meetings throughout SE Asia and China between August 27 and September 11, 2017.
The Singapore EDB is responsible for strategies that enhance Singapore’s position as a global centre for business, innovation, and talent. “We discussed potential business partnerships and agreements that could occur in working with Singapore EDB and with other synergistic partners in Singapore,” Mosman said. “We believe that the CibusDx platform for rapid food safety tests is important in Singapore because they import virtually all of their food.”
CibusDx is a new Salt Lake City based diagnostic company dedicated to developing a state-of-the-art food safety platform. CibusDx technology offers a new testing paradigm, utilizing advanced technology and decentralized testing in conjunction with backend connectivity to centralized data repositories. For more information about CibusDx please visit our website http://cibusdx.com.
NOTICE: This document contains certain forward-looking statements, including without limitation statements regarding CibusDx’s plans for future research and development activities. You are cautioned that such forward-looking statements are not guarantees of future performance and involve risks and uncertainties inherent to CibusDx’s business which could significantly affect expected results, including without limitation progress of product development, ability to raise capital to fund product development, testing and regulatory approval, developments in raw material and personnel costs, and legislative, fiscal, and other regulatory measures. All forward-looking statements are qualified in their entirety by this cautionary statement, and CibusDx undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.
Contact: Jared Bauer 801-796-2918 ext. 104